Daily Derm Times: July 29, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Dermatology Times July 2025 Recap

Dermatology Times is looking back on the top stories in dermatology from the month of July.

J&J Files sBLA for Guselkumab Structural Damage Data

Johnson & Johnson seeks FDA approval to update guselkumab's label, highlighting its unique ability to significantly inhibit joint damage in active psoriatic arthritis.

FDA Grants Fast Track Designation to Nektar's Rezpegaldesleukin in Alopecia Areata

Nektar Therapeutics advances alopecia areata treatment with FDA's Fast Track designation for rezpegaldesleukin, targeting immune modulation in chronic hair loss.

Top 5 Articles of the Month: July

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.

Improving Diagnoses and Trust in Patients With Skin of Color

At Elevate-Derm Summer, Buchi Neita, MCMSc, PA-C, discussed enhancing dermatologic care for patients with skin of color by recognizing characteristics in common conditions and offered strategies to build rapport with patients.

Unraveling Complex Dermatology, Challenging Diagnoses, and the Power of Visuals

Lauren Madigan, MD, shares vital insights on complex dermatology, emphasizing accurate diagnoses and the importance of diversity in dermatologic imagery.

Three A’s Framework Offers Practical SDOH Solutions

Coates addresses social determinants of health in pediatric dermatology, emphasizing their impact on treatment and patient outcomes.